Easton Capital is a New York-based specialist investor that can lead Series A and Series B rounds in healthtech and life sciences, writing checks from $1 million to $10 million.
3 people on the investing team, 3 of them partners who can make the call. Partners are listed first.



Work here and something is wrong? Ask for a correction.


Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Easton Capital reports entry at series a, series b.
Easton Capital reports checks of $1M to $10M.
Yes. Easton Capital says it can lead.
John H. Friedman (Founder & Managing Partner), Kresimir Letinic (Managing Director), Ting Pau Oei (Executive Partner).
No recent activity since September 2026.
Work at Easton Capital? Claim or correct this profile.